Evaluation of the protective effects of α-tocopherol and retinol against ochratoxin A cytotoxicity

Ochratoxin A (OTA), a mycotoxin frequently present in food and feedstuffs, produces a wide range of toxic effects, including cell death via lipid peroxidation. In one human and four animal cell lines we determined the half lethal concentration (LC50) of OTA, its effect on reactive oxygen species (RO...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of nutrition Vol. 91; no. 4; pp. 507 - 512
Main Authors Baldi, A., Losio, M. N., Cheli, F., Rebucci, R., Sangalli, L., Fusi, E., Bertasi, B., Pavoni, E., Carli, S., Politis, I.
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.04.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ochratoxin A (OTA), a mycotoxin frequently present in food and feedstuffs, produces a wide range of toxic effects, including cell death via lipid peroxidation. In one human and four animal cell lines we determined the half lethal concentration (LC50) of OTA, its effect on reactive oxygen species (ROS) production, and its ability to induce cytochrome p450 activity. We also examined the protective effect of α-tocopherol and all-trans-retinol in the most sensitive cell lines (i.e. bovine mammary epithelia, for which LC50 was 0·8μg/ml (24h), and Madin Darby canine kidney, for which LC50 was 4·3μg/ml (48h)). Pre-incubation for 3h with either antioxidant significantly (P<0·05) ameliorated the OTA-induced reduction in cell viability and significantly decreased (P<0·05) ROS production. These findings indicate that oxidative stress is an important factor in OTA cytotoxicity. Supplementation with antioxidant molecules may counteract the short-term toxicity of this mycotoxin.
Bibliography:PII:S0007114504000662
istex:1FE737F2083A421542BC52096556437FF8BD7902
ark:/67375/6GQ-V73KBBRQ-B
ArticleID:00066
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-1145
1475-2662
DOI:10.1079/BJN20041092